When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Genetic Tests Can Help Determine Who is at Risk of ... - AOL

   www.aol.com/genetic-tests-help-determine-risk...

   The analysis showed that both genetic and lifestyle factors increased the risk of death from prostate cancer. Death before 75 was considered an early death, and deaths after 75 were deemed late.

3. New Urine Test for Prostate Cancer May Help Reduce ... - AOL

   www.aol.com/lifestyle/urine-test-prostate-cancer...

   A prostate cancer biomarker test that utilizes 17 genetic markers has demonstrated a high degree of accuracy in screening for serious cancer. The test also significantly reduced unnecessary ...

4. Prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer

   Prostate cancer is a major topic of ongoing research. From 2016 to 2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [122] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost ...

5. Color Genomics - Wikipedia

   en.wikipedia.org/wiki/Color_Genomics

   Color Data, a database containing aggregated genetic and clinical information from 50,000 individuals who took a Color test, [26] helps researchers and scientists identify genotype-phenotype correlations and novel variants for functional analysis, as well as enables data-driven drug discovery and development. It is the largest public database ...

6. PCA3 - Wikipedia

   en.wikipedia.org/wiki/PCA3

   n/a Ensembl ENSG00000225937 n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) Chr 9: 76.69 – 76.86 Mb n/a PubMed search n/a Wikidata View/Edit Human Prostate cancer antigen 3 (PCA3, also referred to as DD3) is a gene that expresses a non-coding RNA. PCA3 is only expressed in human prostate tissue, and the gene is highly overexpressed in prostate cancer ...

7. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.